Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Narrow Band Imaging (NBI) for Early Diagnosis of Oral Squamous Cell Carcinoma (OSCC) and Oral Potentially Malignant Disorders (OPMD)

NCT06438939 is registered in ClinicalTrials.gov with Cardarelli Hospital as lead sponsor.

NCT NCT06438939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06438939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Narrow Band Imaging (NBI) for Early Diagnosis of Oral Squamous Cell Carcinoma (OSCC) and Oral Potentially Malignant Disorders (OPMD)
Lead sponsor
Cardarelli Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2024
Completion date
December 31, 2026
Enrollment
480 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oral potentially malignant disorder, oral squamous cell carcinoma